Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:43 PM
Ignite Modification Date:
2025-12-24 @ 9:43 PM
NCT ID:
NCT06563232
Eligibility Criteria:
Inclusion Criteria:
* Over 18 years old and under 85 years old;
* Imaging examinations (MRI, CT, B-ultrasound) reveal the presence of solid masses (with a diameter \> 1 cm) within the regions accessible by endoscopic ultrasound in the pancreas, peripancreatic area, liver, adrenal gland, kidney, mediastinum, lung, and gastrointestinal submucosa. Biopsy is necessary for the diagnosis of these lesions;
* Must be able to receive examinations in the research center;
* Must be able to sign the informed consent.
Exclusion Criteria:
* Hemoglobin ≤8.0 g/dL;
* Pregnant women;
* Coagulation disorders (PLT \<50,000/mm3,INR \> 1.5);
* Took anticoagulants such as aspirin, warfarin in the latest week;
* Acute pancreatitis in the past two weeks;
* inability to safely perform EUS-TA (eg, cardiorespiratory dysfunction, mental diseases, or drug addiction); refusal or inability to provide an informed consent.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT06563232
Study Brief:
Protocol Section:
NCT06563232